Summary & Overview
CPT 77386: Complex Intensity Modulated Radiation Treatment Delivery
CPT code 77386 is a critical billing code for complex intensity modulated radiation treatment delivery (IMRT), including guidance and tracking. This procedure is widely used in radiation oncology to treat various malignant neoplasms, particularly in the head and neck region, by delivering highly targeted radiation doses. The code is most commonly billed in facility-based settings, such as hospital outpatient departments, where advanced equipment and expertise are required.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, provide coverage for services billed under CPT code 77386. Understanding payer policies and coverage criteria is essential for providers and administrators to ensure accurate billing and reimbursement. The publication offers insights into payer coverage, common modifiers used in billing, associated provider taxonomies, and relevant ICD-10 diagnoses linked to this code. Readers will gain a comprehensive overview of clinical indications, billing practices, and policy updates related to complex IMRT delivery.
Key benchmarks and policy considerations are discussed, along with comparisons to related CPT codes such as 77385 and 77387. The summary provides a clear context for the role of CPT code 77386 in modern radiation oncology, highlighting its importance in the treatment of complex malignancies and its impact on healthcare delivery and reimbursement.
CPT Code Overview
CPT code 77386 represents intensity modulated radiation treatment delivery (IMRT), complex, which includes guidance and tracking when performed. This procedure is a cornerstone in radiation oncology and therapeutic radiology, allowing for precise targeting of malignant tumors while minimizing exposure to surrounding healthy tissue. The service is typically provided in facility-based settings, such as hospital outpatient departments, where advanced technology and specialized staff are available to deliver complex radiation therapy.
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with a malignant neoplasm involving the oral cavity, such as the tongue, lip, gum, floor of mouth, or palate, is referred to a radiation oncology facility for treatment. The clinical workflow involves the radiation oncology physician evaluating the patient, determining the need for intensity modulated radiation therapy (IMRT) due to the complexity of the tumor location and surrounding critical structures. The procedure described by CPT code 77386 is performed in a hospital outpatient department or similar facility setting. The treatment includes advanced guidance and tracking to ensure precise delivery of radiation, minimizing exposure to healthy tissues. The process may involve multiple sessions, and repeat procedures may be necessary depending on the treatment plan.
Coding Specifications
-
Modifiers:
- Modifier
26: Used to indicate the professional component of the service, typically when the physician interprets and supervises the procedure but does not provide the equipment or technical staff. - Modifier
TC: Used for the technical component, representing the use of equipment, supplies, and technical staff without the physician's professional services. - Modifier
59: Indicates a distinct procedural service, used when multiple procedures are performed that are not normally reported together. - Modifier
76: Used when the same procedure is repeated by the same physician on the same day.
- Modifier
-
Provider Taxonomies:
Code Specialty 2085R0001XRadiation Oncology Physician 2085B0100XBody Imaging Physician 2085N0700XNuclear Medicine Physician
These taxonomies represent providers specializing in radiation oncology, body imaging, and nuclear medicine, all of whom may be involved in the delivery and supervision of IMRT procedures.
Related Diagnoses
-
C00.0: Malignant neoplasm of external upper lip- Relevant for IMRT when treating cancers located on the external upper lip.
-
C00.1: Malignant neoplasm of external lower lip- Indicates cancer of the external lower lip, suitable for IMRT targeting.
-
C00.3: Malignant neoplasm of upper lip, inner aspect- Used when the tumor is on the inner aspect of the upper lip, requiring precise radiation delivery.
-
C00.4: Malignant neoplasm of lower lip, inner aspect- Applicable for IMRT in cases involving the inner lower lip.
-
C00.6: Malignant neoplasm of commissure of lip, unspecified- Represents cancer at the lip commissure, where complex IMRT may be needed.
-
C00.8: Malignant neoplasm of overlapping sites of lip- Used when the tumor spans multiple lip regions, necessitating advanced radiation techniques.
-
C01: Malignant neoplasm of base of tongue- IMRT is often used for tumors at the base of the tongue due to proximity to critical structures.
-
C02.0: Malignant neoplasm of dorsal surface of tongue- Indicates cancer on the dorsal tongue, relevant for targeted IMRT.
-
C02.1: Malignant neoplasm of border of tongue- Used for tumors at the tongue border, requiring precise radiation.
-
C02.2: Malignant neoplasm of ventral surface of tongue- Applicable for IMRT when treating the ventral tongue.
-
C02.3: Malignant neoplasm of anterior two‑thirds of tongue, part unspecified- Used for cancers in the anterior tongue, where IMRT can minimize side effects.
-
C02.4: Malignant neoplasm of lingual tonsil- IMRT is relevant for tumors involving the lingual tonsil.
-
C02.8: Malignant neoplasm of overlapping sites of tongue- Used when the tumor involves multiple tongue regions, requiring complex IMRT.
-
C03.0: Malignant neoplasm of upper gum- Indicates cancer of the upper gum, suitable for IMRT.
-
C03.1: Malignant neoplasm of lower gum- Used for lower gum tumors, where IMRT is beneficial.
-
C04.0: Malignant neoplasm of anterior floor of mouth- Relevant for IMRT in cases involving the anterior floor of mouth.
-
C04.1: Malignant neoplasm of lateral floor of mouth- Used for lateral floor of mouth cancers, requiring precise radiation.
-
C04.8: Malignant neoplasm of overlapping sites of floor of mouth- Applicable when the tumor spans multiple floor of mouth regions.
-
C05.0: Malignant neoplasm of hard palate- IMRT is used for tumors of the hard palate to protect adjacent structures.
-
C05.1: Malignant neoplasm of soft palate- Used for soft palate cancers, where IMRT can minimize radiation to healthy tissue.
Related CPT Codes
-
77385: Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; simple- Used for IMRT procedures that are less complex than those described by
77386. It may be selected when the treatment plan does not require advanced guidance or tracking.
- Used for IMRT procedures that are less complex than those described by
-
77387: Guidance for localization of target volume for delivery of radiation treatment delivery, includes intrafraction tracking when performed- Used for the guidance and localization aspect of radiation therapy. This code is often used in conjunction with IMRT delivery codes such as
77386to document the imaging and tracking performed during treatment.
- Used for the guidance and localization aspect of radiation therapy. This code is often used in conjunction with IMRT delivery codes such as
In clinical workflow, 77387 is commonly used together with 77386 to ensure accurate targeting, while 77385 may be an alternative for less complex cases.
National Reimbursement Benchmarks
National mean rates for CPT code 77386 show that BUCA (average commercial) payers reimburse at $593.85, which is higher than the Aetna mean rate of $444.08 and the Blue Cross Blue Shield mean rate of $561.04. Cigna stands out with a significantly higher mean rate of $1,231.65, while UnitedHealth Group is at $589.75. Medicare data is not available in the input.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Aetna has a range of $244.00, Blue Cross Blue Shield $295.00, Cigna $334.25, UnitedHealth Group $276.00, and BUCA $276.00. Aetna exhibits the tightest spread, while Cigna has the widest, indicating greater variability in Cigna's rates nationally.
The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.